RT-310 Safety and Feasibility BPH Study

Clinical trial NCT07264205 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07264205
Sponsor: Resurge Therapeutics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

BPH (Benign Prostatic Hyperplasia)

Start date: 2025-03-13
Primary completion: 2026-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.